+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Human Embryonic Stem Cell (hESC) Research - Global Market Trajectory & Analytics

  • ID: 2228035
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • BD Biosciences
  • GE Healthcare
  • PerkinElmer, Inc.
  • Takara Bio, Inc.
  • TATAA Biocenter AB
  • UK Stem Cell Bank
Global Human Embryonic Stem Cell (hESC) Research Market to Reach $1 Billion by 2027

Amid the COVID-19 crisis, the global market for Human Embryonic Stem Cell (hESC) Research estimated at US$650.9 Million in the year 2020, is projected to reach a revised size of US$1 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Regenerative Medicine, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$717.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Stem Cell Biology Research segment is readjusted to a revised 7.4% CAGR for the next 7-year period.



The U.S. Market is Estimated at $192.2 Million, While China is Forecast to Grow at 6.1% CAGR

The Human Embryonic Stem Cell (hESC) Research market in the U.S. is estimated at US$192.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$177.3 Million by the year 2027 trailing a CAGR of 6.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.1% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Tissue Engineering Segment to Record 5.1% CAGR

In the global Tissue Engineering segment, USA, Canada, Japan, China and Europe will drive the 5.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$39.3 Million in the year 2020 will reach a projected size of US$55.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$116.4 Million by the year 2027.

Select Competitors (Total 25 Featured):
  • Astellas Institute of Regenerative Medicine
  • Asterias Biotherapeutics, Inc.
  • BD Biosciences
  • Cell Cure Neurosciences Ltd.
  • Cellular Dynamics International
  • GE Healthcare
  • PerkinElmer, Inc.
  • Reliance Life Sciences Ltd.
  • Research & Diagnostics Systems, Inc.
  • STEMCELL Technologies, Inc.
  • Stemina Biomarker Discovery, Inc.
  • Takara Bio, Inc.
  • TATAA Biocenter AB
  • Thermo Fischer Scientific Inc.
  • UK Stem Cell Bank
  • ViaCyte, Inc.
Frequently Asked Questions about the Global Market for Human Embryonic Stem Cell (hESC) Research

What is the estimated value of the Global Market for Human Embryonic Stem Cell (hESC) Research?

The Global Market for Human Embryonic Stem Cell (hESC) Research was estimated to be valued at $650.9 Million in 2020.

What is the growth rate of the Global Market for Human Embryonic Stem Cell (hESC) Research?

The growth rate of the Global Market for Human Embryonic Stem Cell (hESC) Research is 6.3%, with an estimated value of $1000.0 Million by 2027.

What is the forecasted size of the Global Market for Human Embryonic Stem Cell (hESC) Research?

The Global Market for Human Embryonic Stem Cell (hESC) Research is estimated to be worth $1000.0 Million by 2027.

Who are the key companies in the Global Market for Human Embryonic Stem Cell (hESC) Research?

Key companies in the Global Market for Human Embryonic Stem Cell (hESC) Research include Astellas Institute of Regenerative Medicine, Asterias Biotherapeutics, Inc., BD Biosciences, Cell Cure Neurosciences Ltd., Cellular Dynamics International, GE Healthcare, PerkinElmer, Inc., Reliance Life Sciences Ltd. and STEMCELL Technologies, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BD Biosciences
  • GE Healthcare
  • PerkinElmer, Inc.
  • Takara Bio, Inc.
  • TATAA Biocenter AB
  • UK Stem Cell Bank

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Stem Cells Research: A Sunrise Sector in Biotechnology Arena
  • Human Embryonic Stem Cells - An Introduction
  • Embryonic Stem Cells - Sources and Cell Culture
  • Comparison on Adult and Embryonic Stem Cells
  • Advantages and Drawbacks of Various Stem Cells
  • Recent Market Activity
  • Human Embryonic Stem Cells - The Market Perspective
  • Timeline for Embryonic Stem Cell Research Activities: Major Events from 1963 through 2014
  • Teratomas - No Longer an Impediment to Stem Cell Therapy Development
  • Human Embryonic and Induced Pluripotent Stem Cell Research Trends
  • Human Embryonic Stem Cell Research: Key Statistical Highlights
  • Research Topics on hESC and hiPSC by Number of Papers Published: 2011-2013
  • Haploid Human Embryonic Stem Cell Line: The New Frontier
  • Human Induced Pluripotent Stem Cells Remains Best Alternative for hESC
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
  • Astellas Institute of Regenerative Medicine (US)
  • Asterias Biotherapeutics, Inc. (US)
  • BD Biosciences (US)
  • Cell Cure Neurosciences Ltd. (Israel)
  • Cellular Dynamics International (US)
  • GE Healthcare (UK)
  • MilliporeSigma (US)
  • PerkinElmer, Inc. (US)
  • Reliance Life Sciences Ltd. (India)
  • Research & Diagnostics Systems, Inc. (US)
  • SABiosciences Corp. (US)
  • STEMCELL Technologies, Inc. (Canada)
  • Stemina Biomarker Discovery, Inc. (US)
  • Takara Bio, Inc. (Japan)
  • TATAA Biocenter AB (Sweden)
  • Thermo Fisher Scientific, Inc. (US)
  • UK Stem Cell Bank (UK)
  • ViaCyte, Inc. (US)
  • Vitrolife AB (Sweden)

3. MARKET TRENDS & DRIVERS
  • Issues Hindering Development of hESC Research
  • Consideration of Best Translational Pathways Pivotal in Ensuring Growth Of hESCs
  • Ethical Issues and Technical Hurdles Bog Down hESC Research

4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Stem Cell Biology Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Stem Cell Biology Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS
  • UNITED STATES
  • Table 11: USA Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 12: USA 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2020 & 2027
  • CANADA
  • Table 13: Canada Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 14: Canada 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2020 & 2027
  • JAPAN
  • Table 15: Japan Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 16: Japan 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2020 & 2027
  • CHINA
  • Table 17: China Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 18: China 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2020 & 2027
  • EUROPE
  • Table 19: Europe Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 20: Europe 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 21: Europe Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 22: Europe 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2020 & 2027
  • FRANCE
  • Table 23: France Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 24: France 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2020 & 2027
  • GERMANY
  • Table 25: Germany Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: Germany 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2020 & 2027
  • ITALY
  • Table 27: Italy Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 28: Italy 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2020 & 2027
  • UNITED KINGDOM
  • Table 29: UK Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 30: UK 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2020 & 2027
  • REST OF EUROPE
  • Table 31: Rest of Europe Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Rest of Europe 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2020 & 2027
  • ASIA-PACIFIC
  • Table 33: Asia-Pacific Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 34: Asia-Pacific 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2020 & 2027
  • REST OF WORLD
  • Table 35: Rest of World Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 36: Rest of World 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2020 & 2027

IV. COMPETITION
  • Total Companies Profiled: 25
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Astellas Institute of Regenerative Medicine
  • Asterias Biotherapeutics, Inc.
  • BD Biosciences
  • Cell Cure Neurosciences Ltd.
  • Cellular Dynamics International
  • GE Healthcare
  • PerkinElmer, Inc.
  • Reliance Life Sciences Ltd.
  • Research & Diagnostics Systems, Inc.
  • STEMCELL Technologies, Inc.
  • Stemina Biomarker Discovery, Inc.
  • Takara Bio, Inc.
  • TATAA Biocenter AB
  • Thermo Fischer Scientific Inc.
  • UK Stem Cell Bank
  • ViaCyte, Inc.
Note: Product cover images may vary from those shown